Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.45
BATS BZX Real-Time Price
As of 3:59pm ET
 +0.19 / +3.61%
Today’s Change
2.80
Today|||52-Week Range
11.40
+7.92%
Year-to-Date

Today’s Trading

Previous close5.26
Today’s open5.26
Day’s range5.23 - 5.65
Volume88,256
Average volume (3 months)1,842,429
Market cap$556.6M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+3.25%
Earnings growth (this year)+33.53%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+26.37%
P/E ratioNM
Price/Sales38.35
Price/Book6.36

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.29-5.72%
CLVSClovis Oncology Inc-0.54-3.69%
ENTAEnanta Pharmaceutica...-0.50-1.68%
AMPHAmphastar Pharmaceut...-0.25-1.99%
Data as of 3:59pm ET, 04/29/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$13.7M
Annual profit (last year)-$123.1M
Net profit margin-900.18%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Gregory P. Madison
Chief Financial Officer
Scott A. Holmes
Corporate headquarters
Boston, Massachusetts

Forecasts

Partner Offers

Search for Jobs